| 1. Amarenco P, Lavalle P, Toulboul PJ. Statins and stroke prevention. Cerebrovasc Dis, 17, suppl 1:81-88, 2004.2. Aronow WS. Pharmacologic therapy of lipid disorders in the elderly. Am J Geriatr Cardiol, 11(4): 247-256, 2002.3. Benner JS, Glynn RJ, Mogun H. Long-term persistence in use of statin therapy in elderly patients. JAMA, 288:455-461, 2002.4. Buckert E. et al. Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients. Am J Geriatr 12(3):225-231, 2003.5. Bucley B. Lipids and stroke. Br J Diabetes Vasc Dis 3(3):170-176, 2003.6. Crsiby M. Cholesterol, statins and dementia: how could lipid-lowering strategies prevent neurodegeneration Geriatrics & Aging 6(8):49-55, september 2003.7. Del Carlo CH, Barreto ACP. Inibidores da HMG CôA redutase e insuficiência cardíaca. Jornal da Insuficência Cardíaca 5(1):5-8, 2004.8. Edwards CJ, Hart DJ, Spector TD. Oral statins and increased mineral density in postmenopausal women. The Lancet 355:2218-2219, 2000.9. Ford I, Blaw GJ, Murphy MB. A prospective study of pravastatin in the elderly at risk (PROSPER): screening experience and baseline characteristics. Curr Controlled Trials Cardiovasc Med 3(8):1-8, 2002.10. Jick H, Zornberg GL et al. Statins and the risk of dementia. The Lancet 356:1627-1631, 2000.11. Mano R. Os redutores da HMGCoA redutase- as vastatinas. Disponível em http://www.manuaisdecardiologia.med.br/Dislipidemia/Lipid5.htm Acesso em 20 mar. 2004.12. Miura DS. Controversies in the treatment of hypercholesterolemia in the elderly: who should be treated and how Am J Geriatr Cardiol 10(3):152-158, 2001.13. Moriguchi EH, Michelon E, Vieira JLC. Dislipidemia em idosos. In: Freitas EV et al. Tratado de Geriatria e Gerontologia. Rio de Janeiro: Guanabara Koogan, 2002. p. 239-248.14. Rockwood K et al. Use of lipid-lowering agents, indication bias and the risk of dementia in community-dwelling elderly people. Arch Neurol 59(2):223-227, 2002.15. Stone NJ. Are statins indicated for the primary prevention of coronary heart disease in octogenarians Protagonist viewpoint. Am J Geriatr Cardiol 12(6):351-356, 2003.16. Tsunekawa T. Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, improves endothelial function in elderly patients within 3 days. Circulation 104:376-379, 2001.17. Watts N. Bisphosphonates, statins, osteoporisis and atherosclerosis. South Med J 95(6):78-582, 2002.18. Mundy G, Garret R, Harris S et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946-49,1999.19. Bauer D, Mundy G, Jamal S et al. Statin use, bone mass and fracture: an anlysis of two prospective studies. J. Bone Miner Res 14 (suppl):S179, 1999.20. Tan ZS, Seshadri S, Beisser A et al. Plasma total cholesterol level as a risk factor for Alzheimer’s disease. The Framingham Study. Arch Intern Med 163:1053-7, 2003.21. Sacco RL, Benson RT, Kargman DE et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 285:2729-35, 2001.22. Botts ML, Elwood PC, Niitin Y et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe.J Epidemiol Community Health 56(suppl 1):I 19-24, 2002. |
